Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects.

Bakker GJ, Schnitzler JG, Bekkering S, de Clercq NC, Koopen AM, Hartstra AV, Meessen ECE, Scheithauer TP, Winkelmeijer M, Dallinga-Thie GM, Cani PD, Kemper EM, Soeters MR, Kroon J, Groen AK, van Raalte DH, Herrema H, Nieuwdorp M.

Physiol Rep. 2019 Aug;7(16):e14199. doi: 10.14814/phy2.14199.

2.

Childhood infection may mediate the relationship between suboptimal intrauterine growth, preterm birth, and adult cardiovascular disease.

Bekkering S, Miller JE, Burgner DP.

Eur Heart J. 2019 Jul 19. pii: ehz438. doi: 10.1093/eurheartj/ehz438. [Epub ahead of print] No abstract available.

PMID:
31324913
3.

Treatment with Statins Does Not Revert Trained Immunity in Patients with Familial Hypercholesterolemia.

Bekkering S, Stiekema LCA, Bernelot Moens S, Verweij SL, Novakovic B, Prange K, Versloot M, Roeters van Lennep JE, Stunnenberg H, de Winther M, Stroes ESG, Joosten LAB, Netea MG, Riksen NP.

Cell Metab. 2019 Jul 2;30(1):1-2. doi: 10.1016/j.cmet.2019.05.014. Epub 2019 Jun 13.

PMID:
31204280
4.

Postnatal inflammation following intrauterine inflammation exacerbates the development of atherosclerosis in ApoE-/- mice.

Bekkering S, Limawan AP, Nguyen MU, Widiasmoko LK, Lu H, Pepe S, Cheung MM, Menheniott TR, Wallace MJ, Burgner DP, Moss TJ.

Clin Sci (Lond). 2019 May 30;133(10):1185-1196. doi: 10.1042/CS20190141. Print 2019 May 31.

PMID:
31088858
5.

Immunometabolism orchestrates training of innate immunity in atherosclerosis.

van Tuijl J, Joosten LAB, Netea MG, Bekkering S, Riksen NP.

Cardiovasc Res. 2019 Jul 1;115(9):1416-1424. doi: 10.1093/cvr/cvz107.

PMID:
31050710
6.

Effects of oral butyrate supplementation on inflammatory potential of circulating peripheral blood mononuclear cells in healthy and obese males.

Cleophas MCP, Ratter JM, Bekkering S, Quintin J, Schraa K, Stroes ES, Netea MG, Joosten LAB.

Sci Rep. 2019 Jan 28;9(1):775. doi: 10.1038/s41598-018-37246-7.

7.

Trained Innate Immunity as a Novel Mechanism Linking Infection and the Development of Atherosclerosis.

Leentjens J, Bekkering S, Joosten LAB, Netea MG, Burgner DP, Riksen NP.

Circ Res. 2018 Mar 2;122(5):664-669. doi: 10.1161/CIRCRESAHA.117.312465. Epub 2018 Jan 24. Review.

PMID:
29367213
8.

Metabolic Induction of Trained Immunity through the Mevalonate Pathway.

Bekkering S, Arts RJW, Novakovic B, Kourtzelis I, van der Heijden CDCC, Li Y, Popa CD, Ter Horst R, van Tuijl J, Netea-Maier RT, van de Veerdonk FL, Chavakis T, Joosten LAB, van der Meer JWM, Stunnenberg H, Riksen NP, Netea MG.

Cell. 2018 Jan 11;172(1-2):135-146.e9. doi: 10.1016/j.cell.2017.11.025.

9.

CCR2 expression on circulating monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT in patients at risk for cardiovascular disease.

Verweij SL, Duivenvoorden R, Stiekema LCA, Nurmohamed NS, van der Valk FM, Versloot M, Verberne HJ, Stroes ESG, Nahrendorf M, Bekkering S, Bernelot Moens SJ.

Cardiovasc Res. 2018 Mar 1;114(3):468-475. doi: 10.1093/cvr/cvx224.

PMID:
29186373
10.

Monocyte and haematopoietic progenitor reprogramming as common mechanism underlying chronic inflammatory and cardiovascular diseases.

Hoogeveen RM, Nahrendorf M, Riksen NP, Netea MG, de Winther MPJ, Lutgens E, Nordestgaard BG, Neidhart M, Stroes ESG, Catapano AL, Bekkering S.

Eur Heart J. 2018 Oct 7;39(38):3521-3527. doi: 10.1093/eurheartj/ehx581. Erratum in: Eur Heart J. 2018 Jun 14;39(23):2182.

11.

Correction for Bekkering et al., "In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes".

Bekkering S, Blok BA, Joosten LAB, Riksen NP, van Crevel R, Netea MG.

Clin Vaccine Immunol. 2017 May 5;24(5). pii: e00096-17. doi: 10.1128/CVI.00096-17. Print 2017 May. No abstract available.

12.

Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in Humans.

Bernelot Moens SJ, Verweij SL, Schnitzler JG, Stiekema LCA, Bos M, Langsted A, Kuijk C, Bekkering S, Voermans C, Verberne HJ, Nordestgaard BG, Stroes ESG, Kroon J.

Arterioscler Thromb Vasc Biol. 2017 May;37(5):969-975. doi: 10.1161/ATVBAHA.116.308834. Epub 2017 Mar 23.

PMID:
28336558
13.

Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity.

Arts RJ, Novakovic B, Ter Horst R, Carvalho A, Bekkering S, Lachmandas E, Rodrigues F, Silvestre R, Cheng SC, Wang SY, Habibi E, Gonçalves LG, Mesquita I, Cunha C, van Laarhoven A, van de Veerdonk FL, Williams DL, van der Meer JW, Logie C, O'Neill LA, Dinarello CA, Riksen NP, van Crevel R, Clish C, Notebaart RA, Joosten LA, Stunnenberg HG, Xavier RJ, Netea MG.

Cell Metab. 2016 Dec 13;24(6):807-819. doi: 10.1016/j.cmet.2016.10.008. Epub 2016 Nov 17.

14.

In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes.

Bekkering S, Blok BA, Joosten LA, Riksen NP, van Crevel R, Netea MG.

Clin Vaccine Immunol. 2016 Dec 5;23(12):926-933. Print 2016 Dec. Erratum in: Clin Vaccine Immunol. 2017 May 5;24(5):.

15.

Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo.

Bekkering S, van den Munckhof I, Nielen T, Lamfers E, Dinarello C, Rutten J, de Graaf J, Joosten LA, Netea MG, Gomes ME, Riksen NP.

Atherosclerosis. 2016 Nov;254:228-236. doi: 10.1016/j.atherosclerosis.2016.10.019. Epub 2016 Oct 12.

16.

Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans.

van der Valk FM, Bekkering S, Kroon J, Yeang C, Van den Bossche J, van Buul JD, Ravandi A, Nederveen AJ, Verberne HJ, Scipione C, Nieuwdorp M, Joosten LA, Netea MG, Koschinsky ML, Witztum JL, Tsimikas S, Riksen NP, Stroes ES.

Circulation. 2016 Aug 23;134(8):611-24. doi: 10.1161/CIRCULATIONAHA.116.020838. Epub 2016 Aug 5.

17.

BCG lowers plasma cholesterol levels and delays atherosclerotic lesion progression in mice.

van Dam AD, Bekkering S, Crasborn M, van Beek L, van den Berg SM, Vrieling F, Joosten SA, van Harmelen V, de Winther MPJ, Lütjohann D, Lutgens E, Boon MR, Riksen NP, Rensen PCN, Berbée JFP.

Atherosclerosis. 2016 Aug;251:6-14. doi: 10.1016/j.atherosclerosis.2016.05.031. Epub 2016 May 19.

18.

Long-term activation of the innate immune system in atherosclerosis.

Christ A, Bekkering S, Latz E, Riksen NP.

Semin Immunol. 2016 Aug;28(4):384-93. doi: 10.1016/j.smim.2016.04.004. Epub 2016 Apr 22. Review.

19.

Plasma cholesteryl ester transfer protein is predominantly derived from Kupffer cells.

Wang Y, van der Tuin S, Tjeerdema N, van Dam AD, Rensen SS, Hendrikx T, Berbée JF, Atanasovska B, Fu J, Hoekstra M, Bekkering S, Riksen NP, Buurman WA, Greve JW, Hofker MH, Shiri-Sverdlov R, Meijer OC, Smit JW, Havekes LM, van Dijk KW, Rensen PC.

Hepatology. 2015 Dec;62(6):1710-22. doi: 10.1002/hep.27985. Epub 2015 Aug 28.

PMID:
26174697
20.

The epigenetic memory of monocytes and macrophages as a novel drug target in atherosclerosis.

Bekkering S, Joosten LA, van der Meer JW, Netea MG, Riksen NP.

Clin Ther. 2015 Apr 1;37(4):914-23. doi: 10.1016/j.clinthera.2015.01.008. Epub 2015 Feb 20. Review.

PMID:
25704108
21.

Trained innate immunity as a mechanistic link between sepsis and atherosclerosis.

Bekkering S, Joosten LA, Netea MG, Riksen NP.

Crit Care. 2014 Nov 25;18(6):645. doi: 10.1186/s13054-014-0645-3. No abstract available.

22.

Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes.

Bekkering S, Quintin J, Joosten LA, van der Meer JW, Netea MG, Riksen NP.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1731-8. doi: 10.1161/ATVBAHA.114.303887. Epub 2014 Jun 5.

PMID:
24903093
23.

Trained innate immunity and atherosclerosis.

Bekkering S, Joosten LA, van der Meer JW, Netea MG, Riksen NP.

Curr Opin Lipidol. 2013 Dec;24(6):487-92. doi: 10.1097/MOL.0000000000000023. Review.

PMID:
24184939

Supplemental Content

Loading ...
Support Center